Zenas BioPharma, Inc. (ZBIO)
36.31
-0.27
(-0.74%)
USD |
NASDAQ |
Dec 31, 16:00
36.25
-0.06
(-0.17%)
After-Hours: 20:00
Zenas BioPharma Total Liabilities (Quarterly): 125.59M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 113.54B |
| Eli Lilly & Co. | 91.08B |
| Royalty Pharma Plc | 9.726B |
| Nektar Therapeutics | 216.26M |
| Rigel Pharmaceuticals, Inc. | 124.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 322.02M |
| Shareholders Equity (Quarterly) | 196.43M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 5.659 |
| Net Debt Paydown Yield | -0.01% |